Lexaria Bioscience Corp. (LEXX)

Lexaria Bioscience Statistics

Total Valuation

LEXX has a market cap or net worth of $25.45 million. The enterprise value is $17.46 million.

Market Cap	25.45M
Enterprise Value	17.46M

Important Dates

The next estimated earnings date is Tuesday, April 8, 2025, after market close.

Earnings Date	Apr 8, 2025
Ex-Dividend Date	n/a

Share Statistics

LEXX has 17.55 million shares outstanding. The number of shares has increased by 93.37% in one year.

Current Share Class	17.55M
Shares Outstanding	17.55M
Shares Change (YoY)	+93.37%
Shares Change (QoQ)	+6.09%
Owned by Insiders (%)	8.85%
Owned by Institutions (%)	5.81%
Float	15.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	41.69
Forward PS	48.83
PB Ratio	2.59
P/TBV Ratio	2.75
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	35.14
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 29.64, with a Debt / Equity ratio of 0.01.

Current Ratio	29.64
Quick Ratio	28.15
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -114.83% and return on invested capital (ROIC) is -69.40%.

Return on Equity (ROE)	-114.83%
Return on Assets (ROA)	-67.50%
Return on Invested Capital (ROIC)	-69.40%
Return on Capital Employed (ROCE)	-76.32%
Revenue Per Employee	$70,989
Profits Per Employee	-$1.05M
Employee Count	7
Asset Turnover	0.07
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.50% in the last 52 weeks. The beta is 1.08, so LEXX's price volatility has been similar to the market average.

Beta (5Y)	1.08
52-Week Price Change	-37.50%
50-Day Moving Average	1.97
200-Day Moving Average	2.73
Relative Strength Index (RSI)	33.85
Average Volume (20 Days)	110,571

Short Selling Information

The latest short interest is 610,356, so 3.48% of the outstanding shares have been sold short.

Short Interest	610,356
Short Previous Month	739,039
Short % of Shares Out	3.48%
Short % of Float	3.89%
Short Ratio (days to cover)	2.49

Income Statement

In the last 12 months, LEXX had revenue of $496,923 and -$7.32 million in losses. Loss per share was -$0.51.

Revenue	496,923
Gross Profit	494,203
Operating Income	-7.25M
Pretax Income	-4.83M
Net Income	-7.32M
EBITDA	-7.17M
EBIT	-7.25M
Loss Per Share	-$0.51

Balance Sheet

The company has $8.12 million in cash and $130,732 in debt, giving a net cash position of $7.99 million or $0.46 per share.

Cash & Cash Equivalents	8.12M
Total Debt	130,732
Net Cash	7.99M
Net Cash Per Share	$0.46
Equity (Book Value)	9.39M
Book Value Per Share	0.56
Working Capital	8.53M

Cash Flow

In the last 12 months, operating cash flow was -$6.50 million and capital expenditures -$67,659, giving a free cash flow of -$6.57 million.

Operating Cash Flow	-6.50M
Capital Expenditures	-67,659
Free Cash Flow	-6.57M
FCF Per Share	-$0.37

Margins

Gross Margin	99.45%
Operating Margin	-1,458.35%
Pretax Margin	-1,475.13%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LEXX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-93.37%
Shareholder Yield	-93.37%
Earnings Yield	-28.76%
FCF Yield	-25.82%

Analyst Forecast

The average price target for LEXX is $9.50, which is 555.17% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.50
Price Target Difference	555.17%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	212.29%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on January 12, 2021. It was a reverse split with a ratio of 0.0333333:1.

Last Split Date	Jan 12, 2021
Split Type	Reverse
Split Ratio	0.0333333:1

Scores

LEXX has an Altman Z-Score of 47.93 and a Piotroski F-Score of 4.

Altman Z-Score	47.93
Piotroski F-Score	4